Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel VEGFR inhibitors prepared and tested by ImClone researchers

July 30, 2004

Novel antitumor and antifungal compounds developed at Gemin X

July 30, 2004

Agensys enters collaboration and license agreement with Genentech

July 29, 2004

Phase I trial of ON-01910Na commences enrollment

July 29, 2004

KOS-862 enters phase Ib trial in combination with Paraplatin for solid tumors

July 29, 2004

Enrollment completed in STELLAR 2 trial of Xyotax

July 29, 2004

Novel propapoptotic agents newly developed at Aponetics

July 29, 2004

Novartis presents new VEGF inhibitors for cancer and ocular disorders

July 29, 2004

Merck researchers claim new tyrosine kinase regulators and their use

July 29, 2004

Promising antitumor activity reported for DRF-1042 in patients with refractory solid tumors

July 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....